Background Knowing the prevalence of multimorbidity among adults across continents is a
crucial piece of information for achieving Sustainable Development Goal 3.4, which calls for …

Globally, the number of people with multiple co-occurring diseases will increase
substantially over the coming decades, with important consequences for patients, carers …

Measuring multimorbidity in research: Delphi consensus study - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

With growing global concern regarding medication-related harm, WHO launched a global
patient safety challenge, Medication Without Harm, in March, 2017. Multimorbidity …

Background Multimorbidity prevalence rates vary considerably depending on the conditions
considered in the morbidity count, but there is no standardised approach to the number or …

Background Multimorbidity poses major challenges to healthcare systems worldwide.
Definitions with cut-offs in excess of≥ 2 long-term conditions (LTCs) might better capture …

Background Multimorbidity affects people of all ages, but the risk factors of multimorbidity in
adolescence are unclear. The aim of this study was to examine preterm birth (< 37 weeks) …

Objectives To determine the prevalence of multiple long-term conditions (MLTC) at whole
English population level, stratifying by age, sex, socioeconomic status and ethnicity. Design …

The prevalence of multiple long term conditions is increasing and therefore there is now a
shift in healthcare from traditional single disease management approaches to ways of …

Sarcopenic dysphagia is characterized by weakness of swallowing-related muscles
associated with whole-body sarcopenia. As the number of patients with sarcopenia …